Amicus Therapeutics Forecast and Stock Analysis
Technical FOLD stock analysis for February 15, 2019.
Amicus Therapeutics gained 1.87% in the last trading day, rising from $11.21 to $11.42 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has been going up and down for this period, and there has been a -5.46% loss for the last 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 1.21 million more shares were traded than the day before. In total, 3.09 million shares bought and sold for approximately $35.27 million.
Close price at the end of the last trading day (Friday, 15th Feb 2019) of the FOLD stock was $11.42. This is 1.87% more than the trading day before Thursday, 14th Feb 2019.
During day the stock fluctuated 4.91% from a day low at $11.20 to a day high of $11.75.
30 day high of the FOLD stock price was $12.49 and low was $10.30.
90 day high was $12.49 and low was $8.27.
52 week high for the Amicus Therapeutics - $17.62 and low - $8.27.
Amicus Therapeutics lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 15.24% during the next 3 months and, with 90% probability hold a price between $10.86 and $14.81 at the end of this period.
Only positive signals in the chart today. Amicus Therapeutics holds buy signals from both short- and long-term moving averages, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down there will be some support from the lines at $11.23 and $11.29. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday February 11, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.
Relative Strength Index (RSI)
RSI14 is 53 and the stock is currently not being overbought or oversold
Support & Resistance
Amicus Therapeutics finds support from accumulated volume at $11.14.
This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $0.55 (4.91%) between high and low. For the last week, the stock has had a daily average volatility of 3.35%.
Our recommended stoploss: $10.84 (-5.05%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 4 days ago.)
Very Low Low Medium High Very High
Evaluation: Buy Candidate
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Buy Candidate.